Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2011-03-07
Summary
This is an observational, physiology pilot study of subjects with overactive bladder, insomnia and normal subjects. No study drug will be given. All subjects will complete a one week sleep diary and a 3-day bladder diary. After one week, subjects meeting eligibility requirements will complete a single sleep night stay in a sleep laboratory setting. During the sleep night stay, subjects will be evaluated using cystometry and polysomnography. In the morning following the sleep night stay, subjects will complete a sleep questionnaire and this will complete their participation in the study.
Conditions
- Bladder Function
Interventions
- PROCEDURE
-
cystometry
recording device measuring pressures though catheters placed in bladder and rectum
- PROCEDURE
-
polysomnography
recording device measuring sleep activity through electrodes attached to the subject
Sponsors & Collaborators
- collaborator INDUSTRY
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Use Central Contact · Duke University
Eligibility
- Min Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-11-30
- Primary Completion
- 2007-07-31
- Completion
- 2007-07-31
Countries
- United States
Study Locations
More Related Trials
-
A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder
NCT00685113 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial
NCT05157295 ·Status: UNKNOWN ·Phase: PHASE4
-
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
NCT03817931 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
NCT00196404 ·Status: COMPLETED ·Phase: PHASE2
-
Caffeine Reduction and Overactive Bladder Symptoms
NCT00754260 ·Status: TERMINATED ·Phase: NA
-
Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients
NCT01530451 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents
NCT01210859 ·Status: WITHDRAWN
-
Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder
NCT00836381 ·Status: COMPLETED ·Phase: PHASE4
-
Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women
NCT03807024 ·Status: COMPLETED
-
Evaluating a Digital Intervention for Overactive Bladder
NCT05170100 ·Status: COMPLETED ·Phase: NA
-
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study
NCT06563193 ·Status: ENROLLING_BY_INVITATION
-
Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder
NCT01604928 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder
NCT02877901 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy Study of VA106483 in Males With Nocturia.
NCT01038843 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.
NCT00323635 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)
NCT00768521 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)
NCT00290563 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity
NCT00335660 ·Status: TERMINATED ·Phase: PHASE2
-
Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder
NCT01925456 ·Status: COMPLETED ·Phase: PHASE1
-
Prevalence and Risk Factors Nocturnal Polyuria in Female OAB
NCT03810027 ·Status: COMPLETED
-
A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder
NCT00321477 ·Status: COMPLETED ·Phase: PHASE2
-
OnabotulinumtoxinA Bladder Injection Study
NCT03523091 ·Status: TERMINATED ·Phase: PHASE4
-
A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency
NCT00911937 ·Status: COMPLETED ·Phase: PHASE4
-
A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)
NCT00231790 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Transcutaneous Versus Percutaneous Posterior Tibial Nerve Stimulation in the Overactive Bladder.
NCT04483817 ·Status: UNKNOWN ·Phase: NA